245 filings
Page 10 of 13
NT 10-Q
zsn4d z04
16 May 22
Notice of late quarterly filing
8:03pm
8-K
qv8yz
16 May 22
Allarity Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
7:54pm
10-K
22ezy66sokisldvbs rw
16 May 22
Annual report
7:12pm
10-Q/A
gtufqis6cgre5v7fmh
16 May 22
Quarterly report (amended)
6:22pm
8-K
q24nt
6 May 22
Entry into a Material Definitive Agreement
5:09pm
8-K
uwpgs7 2ibli
22 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:28pm
8-K
txvd bdjtd12up
18 Apr 22
Entry into a Material Definitive Agreement
5:06pm
424B3
gcx yq7jrc
1 Apr 22
Prospectus supplement
5:21pm
8-K
uvyqnx2xah7 ks4v
1 Apr 22
Entry into a Material Definitive Agreement
4:50pm
8-K/A
dadzrcr
1 Apr 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:30pm
NT 10-K
sbn2ossa9x7hc7o
1 Apr 22
Notice of late annual filing
8:02am
8-K
7ey6fv4nui6d9w
31 Mar 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:16pm
8-K
p1vrtuhd
18 Jan 22
Regulation FD Disclosure
12:00am
8-K
qzfd3xdcqrtmqn
6 Jan 22
Entry into a Material Definitive Agreement
4:30pm
8-K
adooab1
22 Dec 21
Changes in Registrant's Certifying Accountant
5:05pm
8-K
dktsz 7z6xl
22 Dec 21
Allarity Therapeutics Closes Its Recapitalization, Share Exchange, and $20M PIPE Investment; Lists on U.S. Nasdaq Stock Market
5:00pm
424B3
cbyth
21 Dec 21
Prospectus supplement
5:01pm
EFFECT
zmc1brb ay
21 Dec 21
Notice of effectiveness
12:15am
8-K
37z84q
20 Dec 21
Material Modifications to Rights of Security Holders
4:30pm